The Indian SARS-CoV-2 Genomics Consortium (INSACOG ) has suggested a booster dose of anti-Covid vaccines can be considered for the 40-plus age group, prioritising those at high-risk or high-exposure as low levels of neutralising antibodies from existing vaccines may not be sufficient to neutralise the new variant- Omicron.
source https://timesofindia.indiatimes.com/india/covid-19-consider-booster-dose-for-40-plus-age-group-say-genome-scientists/articleshow/88080550.cms
source https://timesofindia.indiatimes.com/india/covid-19-consider-booster-dose-for-40-plus-age-group-say-genome-scientists/articleshow/88080550.cms
No comments:
Post a Comment